InMed Pharmaceuticals Inc. (INM) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $11.08M | +68.5% |
| 2024 | $6.57M | -26.3% |
| 2023 | $8.91M | +44.3% |
| 2022 | $6.18M | -16.1% |
| 2021 | $7.36M | +26.8% |
| 2020 | $5.81M | -41.0% |
| 2019 | $9.84M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $11.08M | +68.5% |
| 2024 | $6.57M | -26.3% |
| 2023 | $8.91M | +44.3% |
| 2022 | $6.18M | -16.1% |
| 2021 | $7.36M | +26.8% |
| 2020 | $5.81M | -41.0% |
| 2019 | $9.84M | — |